Managing Director of Hatteras Discovery and Venture Partner at Hatteras Venture Partners
Vice President for Corporate Engagement, Rose-Hulman Institute of Technology
Serial Entrepreneur and Investor
Partner, Third Rock Ventures
The Washington Biotechnology & Biomedical Association is organizing an event on Jan. 19 titled “P4 Medicine: Why Seattle is Leading the Charge.” The program will focus on how cancer is the best example to date of personalized/genomic medicine. As part of this global topic, the program will illustrate how application of personalized medicine influences the choice of drugs for treatment and how the approach is used to pre-select responders. The program will also illustrate how genomics is being used to pick the best new targets for drug discovery and how this is approach is used for drug validation. For more information on how to register, click here.